Chitosan microspheres in PLG films as devices for cytarabine release

被引:48
作者
Blanco, MD
Gómez, C
Olmo, R
Muñiz, E
Teijón, JM [1 ]
机构
[1] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid 28040, Spain
[2] Univ Complutense Madrid, Fac Biol, Dept Biol Celular, E-28040 Madrid, Spain
关键词
cytarabine; chitosan microspheres; poly(lactide-co-glycolide) film; pharmacokinetic; histological studies;
D O I
10.1016/S0378-5173(00)00408-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytarabine was included in chitosan microspheres and several of these microspheres were embedded in a poly(lactide-co-glycolide) (PLG) film to constitute a comatrix system, to develop a prolonged release form. Chitosan microspheres, in the range of 92 +/- 65 mu m, having good spherical geometry and a smooth surface incorporating cytarabine, were prepared. The cytarabine amount included in chitosan microspheres was 43.7 mu g of ara-C per milligram microsphere. The incorporation efficiency of the cytarabine in microspheres was 70.6%. Total cytarabine release from microspheres in vitro was detected at 48 h. Inclusion of cytarabine-loaded microspheres in poly(lactide-co-glycolide) film initiated a slower release of the drug and, in this way, the maximum of cytarabine released (80%) took place in vitro at 94.5 h. Comatrices, with 8.7 mg of cytarabine, signifying a dose of 34.5 mu g/kg, were subcutaneously implanted in the back of rats. Maximum plasma cytarabine concentration was 18.5 +/- 1.5 mu g/ml, 48 h after the device implantation and the drug was detected in plasma for 13 days. The histological studies show a slow degradative process. After 6 months of implantation, most of the microspheres of the matrix seemed to be intact, the comatrix appeared surrounded by conjunctiva tissue and small blood vessels and nerve packets were detected in the periphery of the implant. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:29 / 39
页数:11
相关论文
共 25 条
[1]   EFFECT OF THE DOSING INTERVAL ON MYELOTOXICITY AND SURVIVAL IN MICE TREATED BY CYTARABINE [J].
AGUR, Z ;
ARNON, R ;
SCHECHTER, B .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (6-7) :1085-1090
[2]   MOLECULAR BIOINTERACTIONS OF BIOMEDICAL POLYMERS WITH EXTRACELLULAR EXUDATE AND INFLAMMATORY CELLS AND THEIR EFFECTS ON THE BIOCOMPATIBILITY, IN-VIVO [J].
ALI, SAM ;
DOHERTY, PJ ;
WILLIAMS, DF .
BIOMATERIALS, 1994, 15 (10) :779-785
[3]  
ALLEN TM, 1992, CANCER RES, V52, P2431
[4]  
Austin P. R., 1986, CHITIN NATURE TECHNO, P279, DOI DOI 10.1007/978-1-4613-2167-5_36
[5]  
BENET LZ, 1986, BASES FARMACOLOGICAS, P19
[6]   Slow releasing of ara-C from poly(2-hydroxyethyl methacrylate) and poly(2-hydroxyethyl methacrylate-co-N-vinyl-2-pyrrolidone) hydrogels implanted subcutaneously in the back of rats [J].
Blanco, MD ;
Trigo, RM ;
Teijón, C ;
Gómez, C ;
Teijón, JM .
BIOMATERIALS, 1998, 19 (7-9) :861-869
[7]   DETERMINATION OF CYTARABINE AND URACIL ARABINOSIDE IN HUMAN-PLASMA AND CEREBROSPINAL-FLUID BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BREITHAUPT, H ;
SCHICK, J .
JOURNAL OF CHROMATOGRAPHY, 1981, 225 (01) :99-106
[8]  
CAPIZZI RL, 1991, SEMIN HEMATOL, V28, P54
[9]   Poly(acrylamide-co-monoethyl itaconate) hydrogels as devices for cytarabine release in rats [J].
Gomez, C ;
Blanco, MD ;
Bernardo, MV ;
Sastre, RL ;
Teijón, JM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (07) :703-712
[10]   N-ACETYLATION IN CHITOSAN AND THE RATE OF ITS ENZYMIC-HYDROLYSIS [J].
HIRANO, S ;
TSUCHIDA, H ;
NAGAO, N .
BIOMATERIALS, 1989, 10 (08) :574-576